iShares S&P Small-Cap 600 Growth ETF (IJT)

189.01 +0.04  +0.02% NASDAQ Dec 10, 16:53 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 188.92
Discount or Premium to NAV 0.07%
Turnover Ratio 45.00%
1 Year Fund Level Flows -852.60M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 2.15% 2.07% 3.95% 72
3M 5.21% 5.25% 5.67% 40
6M 7.40% 7.38% 7.39% 38
YTD 17.94% 17.74% 25.28% 87
1Y 10.50% 10.38% 15.08% 85
3Y 8.32% 8.33% 12.82% 74
5Y 10.42% 10.42% 9.84% 39
10Y 14.43% 14.43% 12.94% 26
15Y 9.89% 9.88% 8.85% 24
20Y -- -- 7.72% --
As of Dec. 9, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.20% 0.50% 0.30%
Stock 99.80% 99.80% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Dec. 6, 2019

Region Exposure

Americas 99.15%
North America 98.30%
Latin America 0.85%
Greater Europe 0.85%
United Kingdom 0.85%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 99.92%
% Emerging Markets 0.08%
As of Dec. 6, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 4.38%
Communication Services 2.86%
Consumer Cyclical 11.40%
Consumer Defensive 4.12%
Energy 2.67%
Financial Services 11.79%
Healthcare 21.67%
Industrials 16.24%
Real Estate 8.73%
Technology 14.01%
Utilities 2.13%
As of Dec. 6, 2019

Stock Market Capitalization

Giant 0.00%
Large 0.00%
Medium 5.31%
Small 89.40%
Micro 5.29%
As of Dec. 6, 2019

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 0.00%
Mid Cap Value 0.00%
Mid Cap Blend 1.33%
Mid Cap Growth 4.06%
Small Cap Value 14.90%
Small Cap Blend 27.63%
Small Cap Growth 52.08%
As of Dec. 6, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
ARWR Arrowhead Pharmaceuticals Inc 1.72% 70.76 +4.41%
MDCO The Medicines Co 1.25% 84.22 +0.08%
GBCI Glacier Bancorp Inc 1.01% 43.67 -0.02%
NEOG Neogen Corp 0.95% 67.28 +0.75%
CBU Community Bank System Inc 0.92% 68.04 +0.24%
VIAV Viavi Solutions Inc 0.92% 14.60 -0.48%
EXPO Exponent Inc 0.92% 65.81 +0.63%
OMCL Omnicell Inc 0.91% 82.06 +2.61%
CNMD Conmed Corp 0.87% 112.16 -0.06%
AJRD Aerojet Rocketdyne Holdings Inc 0.86% 44.00 +1.31%
As of Dec. 6, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks to track the investment results of the S&P SmallCap 600 Growth IndexTM, which measures the performance of the small-capitalization growth sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Growth
Prospectus Objective Small Company
Fund Owner Firm Name iShares
Benchmark Index
S&P SmallCap 600 Growth TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Alan Mason 3.55 yrs
Amy Whitelaw 1.25 yrs
Greg Savage 11.84 yrs
Jennifer Hsui 7.25 yrs
Rachel Aguirre 1.25 yrs

Net Fund Flows

1M 28.25M
3M -124.86M
6M -382.52M
YTD -709.47M
1Y -852.60M
3Y 501.06M
5Y 914.46M
10Y 885.27M
As of Nov. 30, 2019

Risk Info

Beta (5Y) 1.098
Max Drawdown (All) 57.60%
Historical Sharpe Ratio (10Y) 0.9678
Historical Sortino (All) 0.5781
30-Day Rolling Volatility 12.35%
Daily Value at Risk (VaR) 1% (All) 3.53%
Monthly Value at Risk (VaR) 1% (All) 16.32%

Fundamentals

Dividend Yield TTM (12-10-19) 0.93%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 20.70
Weighted Average Price to Sales Ratio 1.751
Weighted Average Price to Book Ratio 2.391
Weighted Median ROE 11.12%
Weighted Median ROA 4.81%
Forecasted Dividend Yield 1.30%
Forecasted PE Ratio 19.75
Forecasted Price to Sales Ratio 1.717
Forecasted Price to Book Ratio 2.398
Number of Holdings 346
As of Dec. 6, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 14.31%
Forecasted Book Value Growth 1.33%
Forecasted Cash Flow Growth 11.42%
Forecasted Earnings Growth 16.62%
Forecasted Revenue Growth -0.97%
As of Dec. 6, 2019

Comparables

Edit

Attributes

Key Dates
Inception Date 7/24/2000
Termination Date
Last Annual Report Date 3/31/2019
Last Prospectus Date 8/1/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.